QualityStocksNewsBreaks Archives - Page 799 of 1390

FridayNov 13, 2020 1:58 pm

QualityStocksNewsBreaks – Net Element Inc. (NASDAQ: NETE), Mullen Technologies Positioned at the Forefront of Reduced EV Manufacturing Costs

Net Element (NASDAQ: NETE) is transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through its merger with privately-held Mullen Technologies Inc. Timing looks optimal for the transition as new research from investment bank UBS finds that the cost to manufacture EVs may be the same as the cost for regular models within the next four years (https://ibn.fm/DW8fZ). This news bodes well for Net Element and Mullen. A recent article discussing this reads, “Mullen recently announced its own plans to start work on a manufacturing facility as well as accept pre-orders for its M05 fully electric SUV.…

FridayNov 13, 2020 1:31 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) CEO Talks Company’s Psychedelic Research, Plans on Live Trading Show

Cybin (NEO: CYBN) CEO Doug Drysdale was featured on a recent episode of TraderTV Live. Broadcast live from the DTTW trading floor, TraderTV Live is the first and only professional trading show on YouTube Live. During the show, Drysdale discussed Cybin’s work on psychedelic medical research, including the company’s current phase 2 study. He also provided an overview of Cybin’s strategic plan moving forward in the development process. In addition, Drysdale talked about the company recent listing move to the NEO exchange and plans for an uplisting to a U.S. exchange in the future. “We recently closed our series B…

FridayNov 13, 2020 12:57 pm

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Initiates Clinical Trial for CBD-Based Therapeutic Candidate – CaniDermRx

Jupiter Wellness (NASDAQ: JUPW), a leading developer of cannabidiol (“CBD”) based therapeutics and wellness products, today announced its initiation of an exploratory clinical study of CaniDermRx. Jupiter’s prescription topical cream candidate, CaniDermRx, combines CBD and aspartame as its active ingredients in the treatment of first degree burns. While, to Jupiter's knowledge, no double-blind, randomized controlled study has demonstrated efficacy of a CBD-aspartame product in the treatment of burns, CaniDermRx may be effective in this indication based on its dual mechanisms of action. “We are pleased to commence this clinical study in what is now our second indication for our CBD-based…

FridayNov 13, 2020 12:26 pm

QualityStocksNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Announces Q3 2020 Results, Operational Update

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a Vancouver, Canada-based company focused on manufacturing pharmaceutical-grade cannabinoids via synthetic biology, has released its financial and operating results for the three and nine months ended September 30, 2020. According to the update, Willow Biosciences reported significant advancement in its operations and strong liquidity. The update reads, “The third quarter represented another significant move forward for us, as we completed our first pilot campaign as part of our final development stage before we begin commercial production, which is anticipated to commence around the middle of 2021. From the pilot, and with our well-advanced downstream…

FridayNov 13, 2020 11:56 am

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) to Host Teleconference to Discuss Q2 2021 Results

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, on Thursday announced its plans to host a teleconference with investors and analysts to review fiscal second-quarter 2021 financial results. President and CEO Richard Wright and Chief Financial Officer David Guarino will host the call at 5:00 PM Eastern Time on Monday, Nov. 16, 2020. In addition, the company will issue a press release outlining its financial results and outlook after the market close on Nov. 16, 2020. Interested parties may join the teleconference by dialing 877-407-3088 (U.S. and…

FridayNov 13, 2020 11:29 am

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Q3 2020 Results, Provides Corporate Update

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products intended to provide treatment for and improve the survival and/or quality of life for patients with unmet medical needs or no alternative treatment, on Thursday released its financial results for the third quarter of 2020. In addition, Processa provided a business update via conference call, for which the replay may be accessed at https://ibn.fm/BdxSB or by dialing 877-481-4010 (Toll-free) or 919-882-2331 (International) and entering replay passcode: 38528. “The third quarter was a period of tremendous value creation. Over that time, we in-licensed important clinical drug…

FridayNov 13, 2020 11:13 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Q3 2020 Results

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, on Thursday announced financial results for the third quarter ended September 30, 2020. According to the update, Foresight ended the quarter with $14.5 million in cash and short-term deposits, GAAP net loss of $11.4 million and non-GAAP net loss for the same period of $10.5 million. “Foresight continued to demonstrate steady progress in the third quarter, as we established new partnerships with influential players in Europe, Japan and China,” said Haim Siboni, CEO of Foresight. “We are confident that our new relationships with leading companies such as…

FridayNov 13, 2020 10:31 am

QualityStocksNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Q2 Results, Provides Update on CNS Pipeline and Business Progress

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today reported its financial results for the fiscal 2021 second quarter ended September 30, 2020. In addition, the company provided an update on its CNS pipeline and business progress. “We see a significant rise in mental health concerns as the global COVID-19 pandemic continues to impact the daily lives of millions of individuals. We are committed to developing innovative therapies that provide relief to those suffering from anxiety and depression, and we are working diligently towards that goal,” said VistaGen…

ThursdayNov 12, 2020 3:30 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Poised at Convergence of AI, Cancer Care

Predictive Oncology (NASDAQ: POAI), a knowledge-driven precision medicine company, focuses on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. The company is set to play a key role as the integration of AI technology within cancer care continues to improve the accuracy and speed of diagnosis, aid in clinical decision-making and lead to better health outcomes. A recent article discussing growing opportunity in this sector reads, “The National Cancer Institute (‘NCI’) in the United States has separately revealed that it is increasingly looking to invest in supporting research and developing infrastructure centered around the usage of…

ThursdayNov 12, 2020 3:13 pm

QualityStocksNewsBreaks – Why ev Transportation Services Inc. Is ‘One to Watch’

ev Transportation Services (“evTS”) is a designer, developer and manufacturer of all-electric lightweight commercial vehicles and fleet management solutions. The company is focused on the essential transportation services market. End-user applications for evTS vehicles include security, parking enforcement, local small package delivery, meter reading, sanitation, parks and recreation, university and corporate campuses, and warehouse operations services. A recent article discussing evTS reads, “The company’s flagship product is the FireFly ESV(R), a high-performance, low-maintenance electric vehicle with zero emissions. This utility vehicle was created specifically to meet the needs of essential services users. The FireFly ESV utilizes the safest Lithium Ion…

Site Search

Company Search

Category: QualityStocksNewsBreaks